Research programme: adenosine A2A receptor antagonists - Pharmacopeia
Alternative Names: PS-246518Latest Information Update: 12 Oct 2009
At a glance
- Originator Pharmacopeia Drug Discovery
- Class
- Mechanism of Action Adenosine A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neurodegenerative disorders; Parkinson's disease
Most Recent Events
- 12 Oct 2009 Discontinued - Preclinical for Neurodegenerative disorders in USA (unspecified route)
- 12 Oct 2009 Discontinued - Preclinical for Parkinson's disease in USA (unspecified route)
- 23 Dec 2008 Pharmacopeia has been acquired by Ligand Pharmaceuticals